Capsule Endoscopy Market Size & Growth Forecast 2027–2036, By Segments (End-use, Type, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Capsule Endoscopy Market size was worth USD 511.7 million in 2026 and is expected to grow at a 7.7% CAGR between 2027 and 2036, crossing USD 1.07 billion by 2036. The industry revenue for 2027 is calculated at USD 544.86 million.
Get more details on this report
Request Free Sample ReportCapsule Endoscopy Market Intelligence Snapshot
Regional Market Dynamics
- North America held 46.16% share in 2026 due to established gastrointestinal diagnostic pathways, advanced imaging technologies, and strong adoption of capsule endoscopy for small bowel disorders and obscure bleeding evaluation.
- Asia Pacific is projected 10.74% CAGR driven by rising access to gastroenterology specialists, expanding healthcare infrastructure, increasing use of minimally invasive diagnostics, and broader screening across large populations.
Segment Momentum
- Hospitals represented 58.3% of the market in 2026 because they offer specialist oversight, diagnostic infrastructure, and integrated care pathways that support consistent capsule endoscopy utilization.
- Colon Capsule Endoscopy is the fastest-growing type, driven by increasing interest in less invasive colon assessment options that offer greater procedural flexibility and patient comfort.
Market Expansion Drivers
- Rising gastrointestinal disorders and colorectal cancer prevalence increasing diagnostic capsule utilization.
- Growing preference for minimally invasive gastrointestinal diagnostics replacing conventional endoscopy.
- AI-enabled lesion detection and magnetically controlled capsules improving diagnostic accuracy.
Leading Market Participants
- Top companies in the capsule endoscopy market include Medtronic plc (Ireland), Olympus Corporation (Japan), CapsoVision, Inc. (United States), IntroMedic Co., Ltd. (South Korea), AnX Robotica Corp. (United States), JINSHAN Science & Technology (Group) Co., Ltd. (China), RF Co., Ltd. (South Korea), Shangxian Minimal Invasive Inc. (China), BioCam GmbH (Germany).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 511.7 million
- 2027 Estimated Market Size: USD 544.86 million.
- Projected Market Size: USD 1.07 billion by 2036
- Growth Forecast: 7.7% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Hospitals (End-use) | Small Bowel Capsule Endoscopy (Type) | OGIB (obscure GI Tract Bleeding) (Application)
- Emerging Opportunity Segment: Hospitals (End-use) | Colon Capsule Endoscopy (Type) | Small Intestine Tumor (Application)
Market Growth Drivers and Industry Trends
Rising gastrointestinal disorders and colorectal cancer prevalence increasing diagnostic capsule utilization
The increasing prevalence of gastrointestinal disorders and colorectal cancer is expanding the need for diagnostic approaches capable of examining difficult-to-access regions of the digestive tract, supporting growth in the capsule endoscopy market. Capsule-based imaging allows patients to undergo gastrointestinal visualization by swallowing a small imaging device that travels naturally through the digestive system, making it particularly useful for evaluating selected intestinal conditions. Greater awareness of gastrointestinal health and the need for earlier identification of abnormalities are encouraging clinicians to consider capsule-based examination where conventional approaches may have limitations in reaching or visualizing specific areas.
Growing preference for minimally invasive gastrointestinal diagnostics replacing conventional endoscopy
Patient and clinician preference for less invasive diagnostic procedures is strengthening the capsule endoscopy market as capsule-based examination can reduce the discomfort, preparation burden, and procedural invasiveness associated with certain conventional gastrointestinal investigations. The ability to capture images during natural passage through the digestive tract makes capsule endoscopy attractive for selected patients who may be reluctant to undergo traditional endoscopic procedures. Its use can also expand diagnostic options for intestinal regions that are challenging to assess through standard endoscopic techniques, supporting greater integration of capsule-based visualization into gastrointestinal diagnostic pathways.
AI-enabled lesion detection and magnetically controlled capsules improving diagnostic accuracy
Integration of artificial intelligence and advanced capsule-control technologies is enhancing the clinical utility of the capsule endoscopy market by addressing two key areas: interpretation of large volumes of gastrointestinal imagery and improved control over capsule positioning. AI-based image analysis can assist clinicians in identifying potential lesions, bleeding sites, polyps, and other abnormalities within extensive image sequences, helping reduce the burden of manual review. Magnetically controlled systems can provide greater directional influence over capsule movement in appropriate settings, allowing more deliberate examination of targeted gastrointestinal areas and improving the ability to obtain diagnostically useful images.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising gastrointestinal disorders and colorectal cancer prevalence increasing diagnostic capsule utilization | 2.00% | High | North America, Europe | High | Near Term |
| Growing preference for minimally invasive gastrointestinal diagnostics replacing conventional endoscopy | 1.70% | High | North America, Asia Pacific | High | Mid Term |
| AI-enabled lesion detection and magnetically controlled capsules improving diagnostic accuracy | 1.40% | High | North America, Europe, Asia Pacific | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America dominated the capsule endoscopy market in 2026 with a 46.16% share in 2026, supported by advanced diagnostic infrastructure and strong adoption of minimally invasive gastrointestinal technologies. The region’s established healthcare system facilitates the integration of innovative diagnostic approaches that can improve visualization of the digestive tract while enhancing patient convenience. Rising awareness of less invasive diagnostic procedures, increasing demand for efficient gastrointestinal evaluation, and strong clinical adoption of digital healthcare technologies continue to strengthen the regional market.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region, benefiting from expanding healthcare infrastructure, increasing awareness of gastrointestinal disorders, and improving availability of advanced diagnostic technologies. Growing healthcare investment and the modernization of diagnostic facilities are creating greater opportunities for capsule-based examination methods. The increasing preference for minimally invasive procedures, combined with broader access to specialized gastrointestinal care, is encouraging healthcare providers to adopt capsule endoscopy technologies across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Diagnostic Workflow IntegrationGermany emphasizes capsule endoscopy systems that integrate smoothly into gastroenterology practices and hospital diagnostic workflows. Clinical adoption in Germany is supported by demand for reliable imaging quality, efficient reporting, and streamlined patient assessment.
France 🇫🇷
Patient-Centered EvaluationFrance promotes capsule endoscopy as a practical option for gastrointestinal assessment when conventional procedures are less suitable. Healthcare providers across France prioritize patient experience, dependable image quality, and efficient clinical interpretation within routine practice.
Italy 🇮🇹
Gastroenterology Practice ExpansionItaly continues to integrate capsule endoscopy into gastroenterology services to broaden access to minimally invasive diagnostic evaluation. Clinical facilities in Italy focus on technologies that improve workflow efficiency while supporting accurate visualization of the gastrointestinal tract.
Japan 🇯🇵
Early Gastrointestinal AssessmentJapan prioritizes capsule endoscopy for comprehensive gastrointestinal evaluation, particularly where minimally invasive diagnostics are preferred. Healthcare providers in Japan focus on imaging accuracy, patient comfort, and technologies that complement established endoscopic services.
South Korea 🇰🇷
Digital Imaging AdvancementSouth Korea supports wider adoption of capsule endoscopy through advanced imaging technologies and digitally enabled diagnostic workflows. Gastroenterology centers in South Korea increasingly value systems that improve image analysis efficiency and enhance patient convenience.
United States 🇺🇸
Non-Invasive DiagnosticsThe U.S. continues to expand the use of capsule endoscopy as clinicians seek less invasive approaches for gastrointestinal evaluation. Healthcare providers in the U.S. prioritize high-quality imaging, efficient data interpretation, and integration into established diagnostic pathways.
Segment Leadership and Growth Trends
Capsule Endoscopy Market Share (%), by End-use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd-use Segment Analysis: Hospitals (Largest & Fastest-Growing Segment)
Hospitals represented the largest share of the capsule endoscopy market, accounting for 58.3% share in 2026, while also emerging as the fastest-growing end-use segment due to their broad access to specialized gastroenterology services, diagnostic infrastructure, and multidisciplinary clinical expertise. Hospitals are well positioned to incorporate capsule endoscopy into diagnostic pathways for patients requiring evaluation of gastrointestinal conditions that may be difficult to assess through conventional approaches. Their ability to combine capsule-based visualization with other diagnostic procedures, specialist consultations, and follow-up care further strengthens utilization. Increasing emphasis on minimally invasive diagnostic techniques is also supporting hospital adoption, as capsule endoscopy can provide valuable visualization while reducing the procedural burden associated with more invasive examinations. The continued expansion of specialized gastrointestinal care within hospital environments is consequently reinforcing the segment's leading position and growth momentum.
Type Segment Analysis: Small Bowel Capsule Endoscopy (Largest Segment) vs Colon Capsule Endoscopy (Fastest-Growing Segment)
Small bowel capsule endoscopy led the capsule endoscopy market with a 57.4% share in 2026, supported by its ability to visualize portions of the small intestine that can be challenging to examine using conventional endoscopic techniques. The technology provides a minimally invasive approach for evaluating gastrointestinal abnormalities and can assist clinicians in investigating conditions affecting areas beyond the routine reach of standard endoscopic procedures. Its non-invasive nature and ability to capture extensive visual information as the capsule travels through the digestive tract have strengthened its clinical utility. Increasing awareness of advanced gastrointestinal diagnostic options and the need for improved visualization of the small bowel continue to support adoption of this established capsule endoscopy application.
Colon capsule endoscopy is growing at the fastest pace as demand increases for less invasive approaches to colorectal examination and gastrointestinal screening. The technology provides an alternative method of visualizing the colon and can be particularly relevant for patients seeking diagnostic options that avoid conventional invasive examination approaches. Growing attention to colorectal health and the importance of detecting gastrointestinal abnormalities at earlier stages are supporting interest in improved visualization technologies. Continued technological refinement, combined with greater awareness of patient-friendly diagnostic alternatives, is creating additional opportunities for colon capsule endoscopy within the broader gastrointestinal diagnostics landscape.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End-use | Hospitals, Outpatient Facilities | Hospitals | Hospitals |
| Type | Small Bowel Capsule Endoscopy, Esophageal Capsule Endoscopy, Colon Capsule Endoscopy, Others | Small Bowel Capsule Endoscopy | Colon Capsule Endoscopy |
| Application | OGIB (obscure GI Tract Bleeding), Crohn's Disease, Small Intestine Tumor, Others | OGIB (obscure GI Tract Bleeding) | Small Intestine Tumor |
Competitive Landscape and Market Positioning
Leading companies in the capsule endoscopy market:
1. Medtronic plc (Ireland)
2. Olympus Corporation (Japan)
3. CapsoVision Inc. (United States)
4. IntroMedic Co. Ltd. (South Korea)
5. AnX Robotica Corp. (United States)
6. JINSHAN Science & Technology (Group) Co. Ltd. (China)
7. RF Co. Ltd. (South Korea)
8. Shangxian Minimal Invasive Inc. (China)
9. BioCam GmbH (Germany)
The capsule endoscopy market is evolving rapidly with advancements in high-resolution imaging, AI-assisted diagnostics, and extended battery performance aimed at improving gastrointestinal disease detection. Continuous product development focused on patient comfort, data accuracy, and non-invasive diagnostic capabilities is strengthening competitiveness and expanding adoption across healthcare facilities.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Medtronic plc (Ireland) | |||||||
| Olympus Corporation (Japan) | |||||||
| CapsoVision Inc. (United States) | |||||||
| IntroMedic Co. Ltd. (South Korea) | |||||||
| AnX Robotica Corp. (United States) | |||||||
| JINSHAN Science & Technology (Group) Co. Ltd. (China) | |||||||
| RF Co. Ltd. (South Korea) | |||||||
| Shangxian Minimal Invasive Inc. (China) | |||||||
| BioCam GmbH (Germany). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| University Hospitals Birmingham | May-26 | The University Hospitals Birmingham NHS Foundation Trust has integrated capsule endoscopy into its gastrointestinal diagnostic services. This implementation of minimally invasive, non-invasive imaging technology is designed to streamline small bowel examination workflows and improve patient access to diagnostic procedures within the hospital’s clinical environment. |
| EgyptAir Hospital | Apr-26 | EgyptAir Hospital has officially launched its capsule endoscopy program, introducing minimally invasive gastrointestinal diagnostic capabilities to its facility. This development marks the expansion of non-invasive screening options for local patients, reflecting the growing adoption of ingestible camera technology in regional healthcare systems. |
| CapsoVision | Nov-25 | CapsoVision submitted an application to the FDA for Breakthrough Device Designation to adapt its capsule endoscopy platform for early-stage pancreatic cancer screening. This strategic initiative aims to expand the clinical utility of capsule diagnostics beyond traditional small-bowel imaging, targeting high-mortality indications where non-invasive, early detection tools are currently limited. |
| Helmholtz Munich | Aug-25 | Helmholtz Munich, in partnership with academic collaborators, has developed a novel endoscopy imaging technique known as "O2E." This advanced technology significantly improves the visualization of early-stage tissue abnormalities, offering potential for enhanced detection of esophageal cancer and signaling technical progress in high-resolution endoscopic screening. |
| Magnetically Controlled Capsule Endoscopy (MCCE) | Aug-25 | Magnetically Controlled Capsule Endoscopy (MCCE) technology has been deployed in Guam, providing a sedative-free, non-invasive diagnostic alternative to traditional endoscopy. This rollout significantly increases regional accessibility to gastrointestinal imaging, offering an efficient solution for patients requiring diagnostic screening without the need for invasive sedation procedures. |
| Public Health System Fiji | Feb-25 | The Public Health System of Fiji has incorporated capsule endoscopy into its clinical diagnostic offerings. This adoption enables the provision of minimally invasive gastrointestinal assessments that support faster patient recovery and allow for the immediate resumption of normal daily activities, effectively enhancing the efficiency of the national diagnostic service. |
| AIG Hospitals | Dec-24 | AIG Hospitals launched the PillBot robotic capsule endoscopy solution to augment or replace conventional endoscopic procedures. This integration of advanced robotic imaging represents a significant shift toward automated, non-invasive gastrointestinal diagnostic workflows, enhancing the precision and accessibility of screening services for complex digestive conditions. |
| Guam Regional Medical City | Nov-24 | Guam Regional Medical City, in partnership with Guam Memorial Hospital, GI Digital, and USC Keck School of Medicine, launched a telemedicine-supported capsule endoscopy service. Funded by a telehealth grant, this program provides a lower-cost alternative to conventional colonoscopies, significantly improving diagnostic access for the local population through remote clinical oversight. |
| Odisha Health Department | Jan-24 | The Odisha Health Department has deployed AI-powered endoscopy systems across its facilities to improve the diagnosis and treatment of gastrointestinal disorders. By integrating artificial intelligence into endoscopic imaging, the department aims to increase clinical accuracy and operational efficiency in identifying and managing diverse digestive tract conditions. |
| GIQuIC | Mar-23 | The GI Quality Improvement Consortium (GIQuIC) partnered with Health Catalyst to modernize its national gastroenterology clinical registry. By utilizing Health Catalyst’s data and analytics platform, GIQuIC is streamlining registry operations for colonoscopy and EGD procedures, facilitating more robust data collection and quality reporting to drive clinical outcomes across the gastroenterology landscape. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Capsule Endoscopy Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Image Analysis Method | Physician-Reviewed Analysis, Computer-Aided Analysis, AI-Assisted Analysis |
| Reimbursement Model | Public/Government Reimbursement, Private Insurance Reimbursement, Self-Pay/Out-of-Pocket |
| Purchasing Model | Direct Purchase, Distributor-Mediated Purchase, Managed Equipment/Service Model |
Capsule Endoscopy Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Gastroenterology Care Pathway Assessment |
|
| AI-Enabled Image Analysis Adoption Outlook |
|
| Emerging Indications Expansion Landscape |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market size of capsule endoscopy?
How is the capsule endoscopy industry projected to perform over the next decade?
How are technology advancements strengthening adoption in the capsule endoscopy market?
Why is capsule endoscopy gaining preference over conventional gastrointestinal diagnostic approaches?
Why do hospitals account for the largest share of the capsule endoscopy market?
Which type segment is growing fastest in the capsule endoscopy market?
Why does North America lead the capsule endoscopy market?
What is supporting Asia Pacific growth in capsule endoscopy?
Which organizations are considered leaders in the capsule endoscopy landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization